CVS vs CMCSA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CMCSA Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Comcast Corp (CMCSA) driven by superior Valuation, Growth & Margin, Options & Structure while CVS counters with relative strength in Momentum & Technical. Fundamentally, CVS trades at 9.3x Forward P/E with 3.1% operating margin (+5.4% YoY revenue) versus CMCSA at 7.1x Forward P/E and 14.7% operating margin (-6.1% YoY). In options structure, CVS sits in CONSOLIDATION (69th %ile IV; Dealer Gamma Walls on Pro) against CMCSA sits in CONSOLIDATION (30th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CVS Revenue | CMCSA Revenue | CVS Op. Margin | CMCSA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $193.9B | $94.5B | 2.1% | 20.1% | CMCSA |
| FY2019 | $256.8B | $108.9B | 4.7% | 19.4% | CMCSA |
| FY2020 | $268.7B | $103.6B | 5.2% | 16.9% | CMCSA |
| FY2021 | $292.1B | $116.4B | 4.6% | 17.9% | CMCSA |
| FY2022 | $322.5B | $121.4B | 2.5% | 11.6% | CMCSA |
| FY2023 | $357.8B | $121.6B | 3.8% | 19.2% | CMCSA |
| FY2024 | $372.8B | $123.7B | 2.3% | 18.8% | CMCSA |
| FY2025 | $402.1B | $123.7B | 1.2% | 16.7% | CMCSA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CVS | CMCSA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $102.4B | $88.3B | Larger Scale | CVS |
| Trailing P/E Ratio Valuation | 9.3x | 7.9x | Lower Multiple | CMCSA |
| Forward P/E Ratio Valuation | 9.3x | 7.1x | Lower Multiple | CMCSA |
| Revenue Growth (YoY) Growth | +5.4% | -6.1% | Higher Growth | CVS |
| Operating Margin (TTM) Profitability | 3.1% | 14.7% | Higher Margin | CMCSA |
| Net Profit Margin Profitability | 2.6% | 9.2% | Higher Margin | CMCSA |
| Return on Equity (ROE) Capital Efficiency | 14.4% | 11.4% | Higher ROE | CVS |
| 52-Week Range Position Momentum | 28% ($70โ$111) | 36% ($20โ$33) | Stronger Trend | CMCSA |
| Beta / 30D Volatility Risk Regime | -0.03ฮฒ ยท 54% Vol | -0.01ฮฒ ยท 32% Vol | Lower Realized Risk | CMCSA |
| Unified Institutional Score Composite Signal | 62.6 / 100 (BUY) | 32.8 / 100 (SELL) | Higher Composite | CVS |